Funding for this research was provided by:
Programme Grants for Applied Research (RP-PG-0216-20001)
Received: 26 August 2022
Accepted: 12 January 2023
First Online: 3 February 2023
: The above updates have been approved by the same research ethics committee which approved our original study as published (19/LO/07/50). All participants completed an online consent form as before.
: Not applicable.
: The author has received speaker fees from Ferring, AbbVie, Takeda and Tillotts.